Prognostic and Treatment-Response Factors in Metastatic Melanoma: Multi-Center Analysis

NCT07256184 · clinicaltrials.gov ↗

COMPLETED

Status

232

Enrollment

OTHER_GOV

Sponsor class

Conditions

Metastatic Malignant Melanoma

Interventions

DRUG: Systemic Therapy for Metastatic Melanoma

Sponsor

Ankara Etlik City Hospital